A Study of HDM2020 in Patients With Advanced Solid Tumors

NCT07098052 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: HDM2020

Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.